BIOMARIN PHAR. DL-,001 revenue breakdown overview

BIOMARIN PHAR. DL-,001 revenue for the last year amounted to 2.19 B EUR, the most of which — 2.19 B EUR — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 1.96 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought BIOMARIN PHAR. DL-,001 698.82 M EUR, and the year before that — 639.37 M EUR.